NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Business Reporter Alana Edgin reviews recent Lubbock area business news and hints at upcoming articles in the weekly Around the Hub column.Read More